We demonstrate that rFVIIIFc engages with CD16, activates CD16+ NK cells, and induces NK cell-mediated cellular cytotoxicity of an anti-FVIII B-cell clone from an inhibitor-positive hemophilia A patient. This evidence concerns the gene F8 and hemophilia A.